"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic ...
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
FDA Commissioner Marty Makary says the agency wants to remove barriers for patients suffering from rare genetic conditions.
Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...
Today there are injected medicines that block proteins produced by the PCSK9 and ANGPTL3 genes in the liver, thus helping the ...
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...
Gene editing has enormous potential to help feed the world’s growing population, but it’s currently difficult, time-consuming ...
Scientists have long sought to understand why some plants are fragrant powerhouses while others remain subtle. Now, a ...
Two companies show hints that switching off certain genes could dramatically lower cholest ...
Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic "base pairs" to a new level of precision, opening the door to safer, more ...